Collaboration Models
Our Strength
Our Partner
Collabration Areas

Our Strengths

If you are seeking partnership in urology, urinary tumor or other related fields, Asieris Pharmaceutical would be your best choice in China. This is based on our strengths in the following areas.

R&D Capability:
Our research team members are from multinational pharmaceutical companies; each with 20+ years of experience in research and management, and with expertise in all major disciplines of new drug R&D.

Advisory Team:
Our advisors include well-known Chinese Key Opinion Leaders in Genito-urinary oncology and urology, as well as experts in pharmacological research, clinical research, and regulatory affairs.

Unique "Drug Repositioning" Know-hows:
We are one of the leading companies in applying the strategy of "using known drugs for rapid clinical validation of novel mechanisms of action, and timely development of follow-on products".

Proven Track Records:
We in-licensed APL-1202's patented technology from the Johns Hopkins University, and have successful collaborations with Okayama University in Japan, Chinese Academy of Medical Sciences Institute of Medicine, and the Chinese Academy of Military Medical Sciences.